Contact the pharmacy for clarification or a replacement
2.2 Measurements For the study population, data were collected at the time of the initial prescription of 3 mg oral semaglutide, including age, duration of diabetes, weight, body mass index (BMI), systolic and diastolic blood pressure, and laboratory test results (e.g., AST, ALT, GTP, urea nitrogen [UN], creatinine [Cr], estimated glomerular filtration rate [eGFR], uric acid [UA], triglycerides, LDL cholesterol [LDL-C], HDL cholesterol [HDL-C], postprandial plasma glucose, HbA1c, and complete blood counts)
With this representative, timely data, we look forward to partnering with more researchers to build representative and accurate real-world studies to power important real-world evidence and complement the insights found in clinical trials.
Novo Nordisk is spending $6 billion (4.7 billion) on a new 170,000m 2 facility at its Kalundborg site in Denmark to be completed in 2029